Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Oct;26(10):2096-2098.
doi: 10.1111/tbj.13870. Epub 2020 May 18.

Ethnicity, recurrence score distribution, and clinical outcomes in ER + HER2-negative breast cancer patients in Israel: A registry analysis

Affiliations

Ethnicity, recurrence score distribution, and clinical outcomes in ER + HER2-negative breast cancer patients in Israel: A registry analysis

Gil Bar-Sela et al. Breast J. 2020 Oct.
No abstract available

PubMed Disclaimer

References

REFERENCES

    1. Albain K, Gray RJ, Sparano JA, et al. Race, ethnicity and clinical outcomes in hormone receptor-positive, HER2-negative, node-negative breast cancer: results from the TAILORx trial. Cancer Res. 2019;79(4 Suppl):Abstract nr GS4-07.
    1. Stemmer SM, Steiner M, Rizel S, et al. Ten-year clinical outcomes in N0 ER+ breast cancer patients with Recurrence Score-guided therapy. NPJ Breast Cancer. 2019;5:41.
    1. Guth AA, Chun Kim J, Schwartz S, et al. The relationship of race, Oncotype DX, and Ki67 in a population highly screened for breast cancer. Breast J. 2017;23:177-181.
    1. Holowatyj AN, Cote ML, Ruterbusch JJ, et al. Racial differences in 21-gene Recurrence Scores among patients with hormone receptor-positive, node-negative breast cancer. J Clin Oncol. 2018;36:652-658.
    1. Lewin R, Sulkes A, Shochat T, et al. Oncotype-DX recurrence score distribution in breast cancer patients with BRCA1/2 mutations. Breast Cancer Res Treat. 2016;157:511-516.

Publication types

Grants and funding